25787767Hu-Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L, Pinheiro EM, Koya RC, Graeber TG, Comin-Anduix B, Ribas AScience translational medicineAntineoplastic Agents; Immunotherapy; MAP Kinase Kinase Kinases; Melanoma; Proto-Oncogene Proteins B-raf; Skin NeoplasmsAnimals; Antigens, Neoplasm; Cell Line, Tumor; Cell Survival; CTLA-4 Antigen; Humans; Imidazoles; Major Histocompatibility Complex; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oximes; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyridones; PyrimidinonesImproved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci Transl Med. 2015 Mar 18; 7(279):279ra41.Sci Transl Med2015-03-18T00:00:002015Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000951Chemicals & Drugs1073240.840388Antigens, NeoplasmD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD000818Living Beings1457265180.249624AnimalsD007093Chemicals & Drugs1061630.909045ImidazolesD007167Procedures1836270.665954ImmunotherapyD008822Living Beings37515370.738445Mice, TransgenicD010091Chemicals & Drugs9150.991604OximesD008810Living Beings55730870.60566Mice, Inbred C57BLD008285Genes & Molecular Sequences41810.958242Major Histocompatibility ComplexD006801Living Beings2262862810.130052HumansObstetrics and Gynecology-Gynecologic OncologyRichardKoyaRichard Koya41.7886000000000087.598699999999994022Koya, RichardProfessorAuthorship 14540780.1336990.1336991authors10.2522has subject areaD008545Disorders1634540.720213MelanomaD020930Chemicals & Drugs32410.978755MAP Kinase Kinase KinasesD048493Chemicals & Drugs701370.902498Proto-Oncogene Proteins B-rafD051379Living Beings980113130.368397MiceD011744Chemicals & Drugs21360.968413PyrimidinonesD060908Chemicals & Drugs491350.947128CTLA-4 AntigenD012878Disorders1535410.69092Skin NeoplasmsD061026Chemicals & Drugs911590.882236Programmed Cell Death 1 ReceptorD045744Anatomy46824210.643233Cell Line, TumorD002470Physiology3269660.814107Cell SurvivalD011728Chemicals & Drugs38510.960436PyridonesD047428Chemicals & Drugs2065890.714193Protein Kinase InhibitorsUniversity of Chicagotrue1ProfessorProfessor